Baidu
map

2021年世界卒中日新闻发布会要点三:我国脑卒中急性期救治技术开展情况

2021-11-05 中国心脑健康 中国心脑健康

10月28日,在2021年世界卒中日新闻发布会上,国家卫生健康委脑卒中防治工程专家委员会副主任委员、复旦大学附属华山医院董强教授介绍了我国脑卒中急性期救治技术开展情况。

近年来,国家卫生健康委脑卒中防治工程委员会、国家神经系统疾病医疗质量控制中心、中国卒中学会携手广大医疗机构及专家积极建立再灌注治疗的规范化培训技术体系,培训指导各地医疗机构持续开展再灌注治疗改进工作,以点带面迅速推广技术。

10月28日,在2021年世界卒中日新闻发布会上,国家卫生健康委脑卒中防治工程专家委员会副主任委员、复旦大学附属华山医院董强教授介绍了我国脑卒中急性期救治技术开展情况。

国家卫生健康委医政医管局组织开展的全国二级及以上医疗机构溶、取栓工作专项调查显示:2010年全国溶栓率仅为0.94%,尚不足1%,2015年仅有0.45%的患者接受了动脉取栓治疗。而发达国家同期的溶栓率和取栓率分别高达约10%和3%。我国急性缺血性卒中再灌注治疗率与发达国家相比存在巨大差距。

十年来,全国各医疗机构专家和医务工作者不断努力探索,聚焦目标,狠抓落实,有力推进了我国急性缺血性卒中再灌注治疗工作。通过一系列努力,我国急性缺血性脑卒中再灌注率得到了明显提升。

据中国脑血管病大数据平台数据统计,2018年,全国开展溶栓的单位达到982家,其中567家常规开展。开展取栓的单位达到459家,其中182家常规开展。2020年全国562家高级中心、1081家防治中心共完成溶栓治疗17.35万例,取栓治疗4.16万例。2020年较2010年,静脉溶栓例数增长36.8倍。2020年较2015年,介入取栓例数增长19.61倍。我国的急性缺血性卒中溶栓率和取栓率分别达到约5.6%和1.4%。溶栓率较2010年国家卫生健康委调研数据增长5.96倍,取栓率较2015年增长2倍多。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2052642, encodeId=1ac52052642b1, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat Dec 25 22:58:58 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678282, encodeId=98b316e828262, content=<a href='/topic/show?id=12025231333' target=_blank style='color:#2F92EE;'>#急性期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52313, encryptionId=12025231333, topicName=急性期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b8027680692, createdName=feifers, createdTime=Sat Dec 04 23:58:58 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943369, encodeId=7a661943369e0, content=<a href='/topic/show?id=d52f20e8136' target=_blank style='color:#2F92EE;'>#世界卒中日#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20781, encryptionId=d52f20e8136, topicName=世界卒中日)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Jan 04 15:58:58 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067469, encodeId=aeec106e46905, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Sat Nov 06 08:15:25 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2021-12-25 宋威
  2. [GetPortalCommentsPageByObjectIdResponse(id=2052642, encodeId=1ac52052642b1, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat Dec 25 22:58:58 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678282, encodeId=98b316e828262, content=<a href='/topic/show?id=12025231333' target=_blank style='color:#2F92EE;'>#急性期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52313, encryptionId=12025231333, topicName=急性期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b8027680692, createdName=feifers, createdTime=Sat Dec 04 23:58:58 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943369, encodeId=7a661943369e0, content=<a href='/topic/show?id=d52f20e8136' target=_blank style='color:#2F92EE;'>#世界卒中日#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20781, encryptionId=d52f20e8136, topicName=世界卒中日)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Jan 04 15:58:58 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067469, encodeId=aeec106e46905, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Sat Nov 06 08:15:25 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2021-12-04 feifers
  3. [GetPortalCommentsPageByObjectIdResponse(id=2052642, encodeId=1ac52052642b1, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat Dec 25 22:58:58 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678282, encodeId=98b316e828262, content=<a href='/topic/show?id=12025231333' target=_blank style='color:#2F92EE;'>#急性期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52313, encryptionId=12025231333, topicName=急性期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b8027680692, createdName=feifers, createdTime=Sat Dec 04 23:58:58 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943369, encodeId=7a661943369e0, content=<a href='/topic/show?id=d52f20e8136' target=_blank style='color:#2F92EE;'>#世界卒中日#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20781, encryptionId=d52f20e8136, topicName=世界卒中日)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Jan 04 15:58:58 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067469, encodeId=aeec106e46905, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Sat Nov 06 08:15:25 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2052642, encodeId=1ac52052642b1, content=<a href='/topic/show?id=a78e3e8631a' target=_blank style='color:#2F92EE;'>#发布会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37863, encryptionId=a78e3e8631a, topicName=发布会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Sat Dec 25 22:58:58 CST 2021, time=2021-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1678282, encodeId=98b316e828262, content=<a href='/topic/show?id=12025231333' target=_blank style='color:#2F92EE;'>#急性期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52313, encryptionId=12025231333, topicName=急性期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b8027680692, createdName=feifers, createdTime=Sat Dec 04 23:58:58 CST 2021, time=2021-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1943369, encodeId=7a661943369e0, content=<a href='/topic/show?id=d52f20e8136' target=_blank style='color:#2F92EE;'>#世界卒中日#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20781, encryptionId=d52f20e8136, topicName=世界卒中日)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a27288, createdName=smallant2002, createdTime=Tue Jan 04 15:58:58 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067469, encodeId=aeec106e46905, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=644b2182796, createdName=1207866fm50(暂无昵称), createdTime=Sat Nov 06 08:15:25 CST 2021, time=2021-11-06, status=1, ipAttribution=)]
    2021-11-06 1207866fm50(暂无昵称)

    谢谢分享

    0

相关资讯

Stroke : 脑中风后,皮质丘脑束病变,影响生活起居

在慢性脑出血患者中,日常生活活动能力的损害与同侧CST的损伤严重程度密切相关

Stroke : 脑中风后谵妄,大脑网络有何变化

谵妄和SN与唤醒网络活动的减少和皮质-皮层下半球连接的不平衡有关。

Lancet Neurology:脑卒中或将成为世界健康“头号杀手”

从1990年到2019年,每年中风和中风导致的死亡人数仍然在大幅增加。如果不紧急实施有效的预防策略,世界各地的卒中医疗负担可能会继续增加,尤其是在低收入国家。

Stroke : 脑中风后,睡眠呼吸暂停可通过训练,得到改善

在中风/短暂性脑缺血发作患者中,与iPSG相比,使用HSAT可以提高OSA的诊断和治疗率,减少日间嗜睡

一生不卒中的方法,太重要了!不用吃药,简单实用

卒中在我国的发病率和死亡率太高了!

Neurology:注意了,体检发现“腔隙性脑梗塞”,未来中风风险成倍增加!

偶然发现的SBI和WMD很常见,与随后的症状性卒中风险增加有关,是预防卒中的一个重要机会。

Baidu
map
Baidu
map
Baidu
map